Truist lowered the firm’s price target on Scotts Miracle-Gro (SMG) to $70 from $90 and keeps a Hold rating on the shares. The firm is adjusting its model after the company’s Q4 earnings miss and FY25 outlook.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- Scotts Miracle-Gro price target lowered to $77 from $90 at UBS
- Scotts Miracle-Gro price target lowered to $85 from $95 at Wells Fargo
- Scotts Miracle-Gro price target lowered to $80 from $85 at JPMorgan
- Scotts Miracle-Gro Reports Strong Fiscal 2024 Results
- Scotts Miracle-Gro calls 2025 EBITDA guidance ‘conservative’